Found Price: When You See It and What a Tier Includes

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

One recurring frustration with GLP-1 telehealth is that the price often stays hidden until after you have filled out an intake. This independent review addresses that for readers researching Found price. Browse the Peptides & GLP-1 education library.

This is editorial analysis from PlexusDx. We hold no commercial relationship with Found or its parent company, and no affiliate links or compensation are involved.

Where a companion cost discussion breaks down the drivers, this piece focuses on price visibility: when the figure appears, what a tier bundles, and the cash-pay reality behind it. Balanced framing, not a buying recommendation. As of April 2026.

When the price actually appears

In many subscription telehealth programs, the headline price surfaces only after a prospective patient completes intake and, sometimes, a clinical review. That sequencing is why straightforward comparison is hard from the outside. The authoritative, current figure for any program lives on Found's own website, not on third-party pages.

What a subscription tier bundles

A tier is not just the drug. It typically packages clinical access, ongoing follow-up, coordination, and shipping alongside the medication, which is why one tier can look expensive next to a bare medication price and still represent a different set of services. Reading the bundle, not just the number, is the useful skill here. A lower sticker that excludes follow-up or ships a different compound is not truly cheaper; it is a smaller package. Comparing tiers only works when you line up what each one actually contains.

The cash-pay reality

Compounded GLP-1 telehealth generally operates as a cash-pay model, sitting outside typical insurance coverage. That means the price you see is usually the price you pay, without a benefit reducing it at the pharmacy counter. Understanding that upfront reframes what "affordable" means in this category, because there is no copay to soften the figure and no deductible math to run. The number on the screen is closer to the number on your card than it would be for a covered retail prescription.

How compound choice moves the number

Price tracks the compound. GLP-1 receptor agonists such as semaglutide and the dual agonist tirzepatide sit at different points, and whether a product is branded (retail) or compounded (503A) shifts the figure further. The trial evidence, STEP for semaglutide (NEJM 2021) and SURMOUNT for tirzepatide (NEJM 2022), describes the compounds, not the tiers, and outcomes vary individually.

The pricing genetics informs but cannot set

No tier price reflects the genetic baseline a GLP-1 compound acts on. Variants in FTO, the fat-mass and obesity-associated gene, and TCF7L2, linked to glucose homeostasis, describe that baseline. These are pathway-level markers, not response predictions. The PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights, including FTO and TCF7L2 variants that map your baseline energy-balance and glucose-regulation biology, so a price decision becomes an informed one.

PlexusDx pricing, shown upfront

By contrast, PlexusDx publishes medication-therapy-management-led pricing through its Weight Management Protocols: Semaglutide Injection at $189 per month, Tirzepatide Injection at $289 per month, and a Microdose at a flat $129 per month. The genetic test is $298, or $99 for program members. You see the number before you commit, not after an intake gate.

No affiliation: PlexusDx is independent of Found and holds no commercial relationship with the programs discussed here.

More from the PlexusDx library: GLP 1 Receptor Agonist, GLP 1 Drugs, GLP 1 Hormone, and What Is GLP 1.

Disclaimer: This article is educational. PlexusDx is not affiliated with Found and compares approaches across the GLP-1 telehealth space, including its own Weight Management Protocols. The Precision Peptide Genetic Test examines how your genes influence peptide-related pathways and does not predict response to any specific medication. Consult a qualified healthcare provider before starting any peptide protocol.

Frequently Asked Questions

Why is Found's price not shown right away?

Many subscription telehealth programs reveal the headline figure only after intake or clinical review, which makes upfront comparison difficult. The most reliable current number appears on the brand's own site rather than on third-party pages, so verify there before drawing conclusions about what you would pay.

What does a subscription tier actually include?

A tier usually bundles clinical access, ongoing follow-up, coordination, and shipping along with the medication. That is why a tier price can look higher than a bare drug cost while covering more services. Reading the full bundle, not just the top-line number, tells you what you are buying.

Does insurance apply to compounded GLP-1 telehealth?

These programs generally run as cash-pay and sit outside typical insurance coverage, so the price you see is usually the price you pay. That reality reframes affordability in the category and is worth confirming on any program's own site before you enroll.

How does PlexusDx pricing differ on visibility?

PlexusDx publishes its figures upfront: Semaglutide Injection at $189 monthly, Tirzepatide Injection at $289 monthly, a Microdose at a flat $129 monthly, and the genetic test at $298 or $99 for members. You see the price before committing rather than after an intake gate.

Keep reading in the PlexusDx Education Hub. Browse Peptides & GLP-1 education.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.